Elsevier MDL Release: New Approach For Integrating R&D Data And Workflows Gains Momentum In Pharmaceutical Industry

SAN RAMON, Calif.--(BUSINESS WIRE)--More than 75 pharmaceutical, biotechnology and chemical companies have licensed the new, open-technology MDL® Isentris® system to address common R&D challenges, Elsevier MDL has announced. Leading research companies turning to the new-generation Isentris system include more than half of Elsevier MDL’s top 30 customers.

Back to news